Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults

by Vanbelle Sophie, Albert Adelin, Deprez Manuel, Artesi Maria, Nguyen-Khac Minh T, Martin Didier H, Robe Pierre A, Califice Stephane, Bredel Markus, Bours Vincent
Published 2009-10-01